KDA
- Current
- Browse
- Collections
-
For contributors
- For Authors
- Instructions for authors
- Article processing charge
- For Reviewers
- Instructions for reviewers
- How to become a reviewer
- Best reviewers
- For Readers
- Readership
- Subscription
- Permission guidelines
- About
- Editorial policy
Search
- Page Path
- HOME > Search
Editorial
- The Beneficial Effect of Glycemic Control against Adverse Outcomes in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
- Dong-Hwa Lee
- Diabetes Metab J. 2023;47(4):484-486. Published online July 27, 2023
- DOI: https://doi.org/10.4093/dmj.2023.0165
- 3,840 View
- 153 Download
- 2 Web of Science
- 2 Crossref
-
PDF
PubReader 
ePub -
Citations
Citations to this article as recorded by
- Glucosamine supplementation attenuates progression of metabolic dysfunction-associated steatotic liver disease and related comorbidities
Tom Ryu, Young Chang, Jeong-Ju Yoo, Sae Hwan Lee, Soung Won Jeong, Sang Gyune Kim, Young Seok Kim, Hong Soo Kim, Keungmo Yang, Jae Young Jang
Clinical Nutrition.2025; 47: 119. CrossRef - Diagnostic Significance of Elabela, FABP1, and FABP2 as Biomarkers of Diabetic Nephropathy in Type 2 Diabetic Patients
Samah M. Mohamed, Kholoud S. Ramadan, Ahmed A. Saedii, Ehab A. Ibrahim
Indian Journal of Clinical Biochemistry.2024;[Epub] CrossRef
- Glucosamine supplementation attenuates progression of metabolic dysfunction-associated steatotic liver disease and related comorbidities
First
Prev
